Who is sponsoring NCT04449341?

NCT04449341 is sponsored by C.R.Darnall Army Medical Center.

What drugs are being tested in NCT04449341?

Interventions in NCT04449341: Oculus Go headset with Ocean Rift application.

What condition does NCT04449341 study?

NCT04449341 studies Procedural Anxiety, Procedural Pain.

Is NCT04449341 still recruiting?

NCT04449341 is currently completed. Last updated 13 July 2021.

Are results published for NCT04449341?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-07-13 · How we verify

NCT04449341

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can Virtual Reality Reduce Pain and Anxiety During Blood Draw

Completed NA Results posted Last updated 13 July 2021

What this trial tests

NA trial testing Oculus Go headset with Ocean Rift application in Procedural Anxiety in 59 participants. Completed in 9 July 2020.

Timeline

10 June 2020

Primary endpoint
9 July 2020

9 July 2020

Quick facts

Lead sponsor	C.R.Darnall Army Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	59
Start date	10 June 2020
Primary completion	9 July 2020
Estimated completion	9 July 2020
Sites	1 location across United States

Drugs / interventions tested

Oculus Go headset with Ocean Rift application

Conditions studied

Procedural Anxiety — all drugs for Procedural Anxiety →
Procedural Pain — all drugs for Procedural Pain →

Sponsor

C.R.Darnall Army Medical Center

Who can join

Adults 18 to 50, any sex, with Procedural Anxiety or Procedural Pain. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Procedural Pain Primary · 2 months

Determine if use of Oculus Go headset reduces procedural pain perception utilizing the visual analog scale, which measures pain on a linear scale from 0 to 100 millimeters, with 0 being no pain and 100 being maximum pain

Group	Value	95% CI
Standard Care Venipuncture With Additional of Virtual Reality	6.50	0.25 – 30.75
Standard Care Venipuncture Without Addition of Virtual Reality	5.00	1.00 – 24.25

Procedural Anxiety Secondary · 2 months

Determine if use of Oculus Go headset reduces procedural anxiety utilizing the visual analog scale, which measures anxiety on a linear scale from 0 to 100 millimeters, with 0 being no anxiety and 100 being maximum anxiety

Group	Value	95% CI
Standard Care Venipuncture With Additional of Virtual Reality	5	1.00 – 24.25
Standard Care Venipuncture Without Addition of Virtual Reality	6.5	.25 – 30.75

Sponsor's own description

Adult patients aged 18-50 undergoing blood draw for routine lab evaluation will be randomized to a control group or experimental group to assess if the use of virtual reality reduces procedural pain (primary outcome) and procedural anxiety (secondary outcome) during venipuncture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Procedural Anxiety

Currently open trials in the same condition.

NCT07427862 — Virtual Reality (VR) for Interventional Radiology (IR) Procedures · recruiting
NCT06346171 — VR Augmented Human Delivered Integrative Psychotherapy for Colonoscopy Procedural Anxiety and Pain · NA · active not recruiting
NCT05895383 — Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy · Phase 4 · recruiting
NCT05645224 — VR-PAT for Pain and Anxiety Management During Pediatric Dermatologic Laser Procedures · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04449341 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by C.R.Darnall Army Medical Center
Last refreshed: 13 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04449341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing